Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on November 9, 2018. The Company is an emerging growth company incorporated in Delaware with principal executive offices in San Francisco, California. The filing addresses a specific regulatory event regarding the Company's listing status on The Nasdaq Stock Market.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point disclosed is that the Company currently holds stockholders' equity of at least $5 million, which qualifies it for a potential extension of its grace period if it meets other listing criteria.
Material Changes
The primary material event is the receipt of a letter from the Nasdaq Listing Qualifications Staff on November 9, 2018. The letter notified the Company that its common stock bid price had closed below the minimum $1.00 per share requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Contingencies
- Grace Period: The Company has been granted a 180-calendar-day grace period, expiring on May 8, 2019, to regain compliance.
- Compliance Requirement: To maintain listing, the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during the grace period.
- Extension Criteria: If the Company fails to meet the bid price requirement by May 8, 2019, it may qualify for a second 180-day grace period if it meets the market value of publicly held shares requirement and all other initial listing standards (excluding the bid price).
- Delisting Risk: If the Company fails to regain compliance or secure an extension, its common stock will be subject to delisting from Nasdaq.
- Forward-Looking Statements: Management states it is working to regain compliance but provides no assurance that it will succeed or that Nasdaq will grant further extensions.
Investor Verification Checklist
- Verify the current trading price of Jaguar Health common stock to assess progress toward the $1.00 threshold.
- Monitor the Company's stockholders' equity to ensure it remains above the $5 million threshold required for potential extensions.
- Review the Company's 2017 Form 10-K for detailed risk factors and financial condition as referenced in the filing.
- Track any future announcements regarding the Company's ability to meet the 10-day consecutive closing price requirement before the May 8, 2019 deadline.